NABRIVA THERAPEUTICS PLC (NBRV)
IE000OZRGNV6 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 1.80M | 12.41M | 47.66M | 41.40M | 86.00M | |||
| Marketable Securities | N/A | 0.00 | 16.00K | 0.00 | 200.00K | |||
| Receivables | 10.51M | 6.74M | 12.75M | 3.90M | 2.70M | |||
| Inventories | 9.03M | 9.68M | 14.51M | 5.80M | 700.00K | |||
| Other Current Assets | 2.36M | 2.27M | 5.33M | 6.10M | 1.60M | |||
| Total Current Assets | 23.69M | 31.10M | 80.27M | 57.20M | 91.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 263.00K | 280.00K | 233.00K | 800.00K | 2.50M | |||
| Intangibles | 2.00K | 3.00K | 31.00K | 100.00K | 100.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 644.00K | 661.00K | 644.00K | 1.20M | 2.90M | |||
| TOTAL ASSETS | 24.34M | 31.77M | 80.91M | 58.40M | 94.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 197.00K | 4.83M | 3.77M | 2.00M | N/A | |||
| Accrued Expenses | 16.88M | 13.24M | 8.29M | 11.00M | 8.10M | |||
| Accounts Payable | 6.98M | 5.43M | 4.37M | 2.90M | 4.70M | |||
| Other Current Liabilities | 3.95M | 4.10M | 5.91M | 2.60M | 3.90M | |||
| Total Current Liabilities | 28.00M | 27.61M | 22.34M | 18.50M | 16.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 345.00K | 388.00K | 4.26M | 5.70M | 34.50M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 352.00K | 479.00K | 954.00K | 1.10M | 1.70M | |||
| Total Non-Current Liabilities | 697.00K | 867.00K | 5.22M | 6.80M | 36.20M | |||
| TOTAL LIABILITIES | 28.70M | 28.47M | 27.56M | 25.30M | 52.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -4.42M | 3.23M | 52.76M | 32.90M | 40.30M | |||
| Common Shares | 32.00K | 32.00K | 567.00K | 200.00K | 900.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 27.00K | 27.00K | 27.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 3.20M | 3.20M | 2.27M | 21.10M | 9.50M | |||
| Tangible Book Value per Share | -1.36 | 1.03 | 23.50 | 1.56 | 4.34 | |||
| Total Shareholders' Equity | -4.36M | 3.29M | 53.35M | 33.10M | 41.30M | |||
| TOTAL LIABILITIES AND EQUITY | 24.34M | 31.77M | 80.91M | 58.40M | 94.10M | |||
| Statistics | ||||||||
| Debt/Equity | -0.08 | 0.12 | 0.08 | 0.17 | 0.84 | |||
| Current Ratio | 0.85 | 1.13 | 3.59 | 3.09 | 5.49 | |||
| Return On Assets (ROA) | -222.15% | -180.03% | -61.12% | -118.97% | -87.95% | |||
| Return On Equity (ROE) | N/A | -1736.56% | -92.69% | -209.91% | -200.39% | |||
All data in USD